🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lida A. Mina

Mayo Clinic in Arizona

ORCID: 0000-0003-2606-9922

Also affiliated with Mayo Clinic Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial”.

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2098
N/A
0.899DataRank · unranked
401 citations

Sara A. Hurvitz, Lida A. Mina, Hope S. Rugo, Ki Hoon Lee, Anthony Gonçalvès +15 more

Precise and Programmable Detection of Mutations Using Ultraspecific Riboregulators

Cell(2020)10.1016/j.cell.2020.02.011
N/A
0DataRank · unranked
110 citations

Duo Ma, Kaiyue Wu, Lida A. Mina, Rebecca C. Luiten, Yàn Liú +3 more

Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.016
N/A
0DataRank · unranked
3 citations

Minxing Chen, Michael T. Walsh, Amanda L. Eppolito, Molly H. Klein, Kelly B. Teed +51 more

A randomized phase 2 non-inferiority trial of (Z)-endoxifen and exemestane + goserelin as neoadjuvant treatment for premenopausal women with ER+/HER2- breast cancer (EVANGELINE).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps633
N/A
0DataRank · unranked
3 citations

Vera J. Suman, Lida A. Mina, Pooja Advani, John George Knecht, Heather Heather Fraser +2 more

Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer

Murdoch Research Repository (Murdoch University)(2023)10.1101/2023.09.18.558136
N/A
0DataRank · unranked
3 citations

Ruthanne Teo, Luke Foster, Daniel Saha, Lida A. Mina, Donald W. Northfelt +8 more

Resistance Management for Cancer: Lessons from Farmers

arXiv (Cornell University)(2023)10.48550/arxiv.2304.00402
N/A
0DataRank · unranked
0 citations

Valerie Harris, Stefania E. Kapsetaki, Daniel Saha, Zachary Compton, Rezvan Yousefi +12 more

Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer

Cancers(2024)10.3390/cancers16020257
N/A
0DataRank · unranked
10 citations

Ruthanne Teo, Luke Foster, Daniel Saha, Lida A. Mina, Donald W. Northfelt +8 more

Resistance Management for Cancer: Lessons from Farmers

Cancer Research(2024)10.1158/0008-5472.can-23-3374
N/A
0DataRank · unranked
6 citations

Valerie Harris, Stefania E. Kapsetaki, Shrinath Narayanan, Daniel Saha, Zachary T. Compton +13 more